Compare Charles River Laboratories Intl. Inc (CRL) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Matson Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Matson Inc trades at $225.67 (market cap $6.81B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 2.1× Matson Inc's market cap, and Matson Inc pays a 0.67% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Matson Inc for 23 Days on average.
| CRL | MATX | |
|---|---|---|
Market Cap | $14.23B | $6.81B |
Volume | 1,176,885 | 255,080 |
Sector | Health | Industrials |
52-Week High | $310.77 | $238.60 |
52-Week Low | $149.93 | $88.05 |
Typical Hold Time | 33 Days | 23 Days |
Enterprise Value | $17.06B | $7.41B |
Dividend Yield | — | 0.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.
The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.
Matson (MATX) trades at $227.79, up 2.18% today, with strong technical momentum showing bullish moving averages and support at $225. The company demonstrates solid fundamentals with Q2 2026 EPS of $4.27 beating expectations by 12.7% and consistent revenue growth from $3.34B to $3.5B projected for 2026. Recent analyst upgrades to Strong Buy highlight improving earnings prospects.
MATX presents a compelling investment case with attractive valuation (P/E 15.37), strong profitability (ROE 17.21%), and positive earnings momentum. Key risks include freight market volatility and competitive pressures. Wall Street consensus remains bullish with 67% buy ratings and 27.3% upside potential, supported by institutional accumulation and dividend stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
